Ariss(Der Hovanessian)DerhovanessianMDMSCR
Pulmonology • Los Angeles, CACritical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine, Pulmonary Vascular Medicine
Associate Director, UCLA Lung & Heart-Lung Transplant Program; Director, UCLA Lymphangioleiomyomatosis Clinic
Dr. Derhovanessian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
200 Medical Plaza, Suite 365-B
Los Angeles, CA 90095Phone+1 310-825-7921Fax+1 310-825-7921
Summary
- Dr. Ariss DerHovanessian is a pulmonologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 12 years. He specializes in lung transplantation, critical care, pulmonary vascular disease, and interstitial lung disease.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2005 - 2008
David Geffen School of Medicine at UCLAClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2026- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsQuantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.Samuel Weigt, G. Kim, Heather Jones, Allison Ramsey, Olawale Amubieya
Transplantation. 2021-09-16 - 3 citationsThe allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.Michael Y. Shino, Qiuheng Zhang, Ning Li, Ariss Derhovanessian, Allison Ramsey
American Journal of Transplantation. 2021-08-31 - 1 citationsSweet's Syndrome: A First in Human Lung Transplantation.Allison Ramsey, W. Dean Wallace, Fereidoun Abtin, Jeffrey D. Suh, Lloyd L. Liang
Chest. 2021-08-01
Other Languages
- Armenian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
